Back
HFA Premium Access

Sodium-glucose co-transporter 2 inhibition with empagliflozin improves cardiac function in non-diabetic rats with heart failure after myocardial infarction

Session: Moderated Poster Session - Basic Science
Topic: Pharmacotherapy
Speaker: Doctor S. Yurista (Cleveland, US)
Event: Heart Failure 2019

Congress Presentation

Add to my library

Like

About the speaker

Doctor Salva Reverentia Yurista

Cleveland Clinic Hospital, Cleveland (United States of America)
0 follower

7 more presentations in this session

Serum uric acid levels and xanthine oxidase activity in chronic heart failure patients with chronic kidney disease

Speaker: Doctor M. Kolomiiets (Kharkiv, UA)

Access
Abstract
Slides
Like
Thumbnail

Epigenetic changes in heart failure cohorts: novel insights into methylation changes of protein and RNA coding genes in human cardiac tissue

Speaker: Doctor N. Glezeva (Dublin, IE)

Access
Abstract
Like
Thumbnail

Rest myocardial perfusion defects are related to increased 99mTc-sestamibi washout and inflammation in CCC

Speaker: Associate Professor M. Simoes (Ribeirao Preto, BR)

Access
Abstract
Slides
Like
Thumbnail

Different pathophysiological pathways between ischaemic and non-ischaemic heart failure

Speaker: Miss R. Woolley (Groningen, NL)

Access
Abstract
Like
Thumbnail

Generation and phenotyping of a novel knock-in mouse model of arrhythmogenic cardiomyopathy

Speaker: Miss A. Di Bona (Padova, IT)

Access
Abstract
Like
Thumbnail

Access the full session

Moderated Poster Session - Basic Science

Speakers: Doctor S. Yurista, Doctor M. Kolomiiets, Doctor N. Glezeva, Associate Professor M. Simoes, Miss R. Woolley...
Access
Like
Thumbnail

About the event

Image

Heart Failure 2019

25 May - 28 May 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources